Who invested in IFM Therapeutics?
IFM Therapeutics's investors include Omega Funds, Atlas Venture, Novartis, Abingworth and Atlas Venture & Abingworth. Omega Funds led its latest round.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$83Mraised across 2 rounds since 2016, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by Cbs8SEC filing: $17M sold, first sale Jun 2016
From IFM Therapeutics's own website and the SEC filings it signed: 1 founder, 8 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
IFM Therapeutics's investors include Omega Funds, Atlas Venture, Novartis, Abingworth and Atlas Venture & Abingworth. Omega Funds led its latest round.
IFM Therapeutics has raised $83M across 2 rounds since 2016.
IFM Therapeutics's most recent round was an Undisclosed round of $56M in Dec 2019, led by Omega Funds.
Its most recent round, $56M in Dec 2019, is also its largest on record.
IFM Therapeutics's first round on record, in Jun 2016, was backed by Atlas Venture & Abingworth.
IFM Therapeutics's latest named round is an Undisclosed round, in Dec 2019.
IFM Therapeutics is based in the United States.
Omega Funds led the Undisclosed round in 2019.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.